| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Apolipoproteins | 3 | 2017 | 33 | 2.06 | Why? |
| Apolipoprotein L1 | 6 | 2018 | 161 | 1.95 | Why? |
| Lipoproteins, HDL | 3 | 2017 | 154 | 1.33 | Why? |
| Kidney Diseases | 4 | 2020 | 1434 | 1.28 | Why? |
| Patient Readmission | 5 | 2020 | 1543 | 1.04 | Why? |
| Acute Kidney Injury | 10 | 2021 | 5762 | 0.94 | Why? |
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 55 | 0.89 | Why? |
| Kidney Failure, Chronic | 6 | 2019 | 3222 | 0.84 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 2 | 2018 | 86 | 0.83 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2018 | 229 | 0.81 | Why? |
| Blood Pressure | 4 | 2017 | 2198 | 0.75 | Why? |
| Renal Dialysis | 9 | 2021 | 4358 | 0.69 | Why? |
| Sodium-Glucose Transporter 2 | 1 | 2017 | 111 | 0.66 | Why? |
| Glomerular Filtration Rate | 5 | 2018 | 1262 | 0.66 | Why? |
| African Americans | 7 | 2019 | 3363 | 0.66 | Why? |
| Trimetazidine | 1 | 2015 | 5 | 0.61 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.60 | Why? |
| Lower Extremity | 2 | 2018 | 593 | 0.60 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.59 | Why? |
| New York City | 15 | 2021 | 7432 | 0.58 | Why? |
| Peripheral Arterial Disease | 2 | 2018 | 471 | 0.57 | Why? |
| Donor Selection | 2 | 2020 | 804 | 0.54 | Why? |
| Renal Insufficiency, Chronic | 7 | 2018 | 2654 | 0.54 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.54 | Why? |
| Kidney | 5 | 2020 | 3648 | 0.53 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.52 | Why? |
| Vasodilator Agents | 1 | 2015 | 344 | 0.46 | Why? |
| Graft Survival | 4 | 2018 | 587 | 0.45 | Why? |
| Hospitalization | 14 | 2021 | 54280 | 0.43 | Why? |
| Hemorrhage | 2 | 2020 | 3013 | 0.43 | Why? |
| Anticoagulants | 3 | 2020 | 9563 | 0.42 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.39 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.37 | Why? |
| Cerebrovascular Disorders | 1 | 2017 | 1040 | 0.37 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.37 | Why? |
| Contrast Media | 1 | 2015 | 1011 | 0.36 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.34 | Why? |
| Kidney Function Tests | 3 | 2018 | 520 | 0.34 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.34 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.33 | Why? |
| Chi-Square Distribution | 3 | 2017 | 961 | 0.31 | Why? |
| Amputation | 2 | 2018 | 331 | 0.29 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.27 | Why? |
| Diabetic Nephropathies | 2 | 2018 | 315 | 0.26 | Why? |
| Kidney Transplantation | 3 | 2018 | 5397 | 0.25 | Why? |
| Comorbidity | 9 | 2021 | 34796 | 0.24 | Why? |
| Odds Ratio | 4 | 2017 | 5861 | 0.24 | Why? |
| Renal Insufficiency | 2 | 2020 | 810 | 0.24 | Why? |
| Hospital Mortality | 11 | 2021 | 22087 | 0.24 | Why? |
| Atrial Fibrillation | 1 | 2016 | 2320 | 0.23 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2018 | 10649 | 0.23 | Why? |
| Aged | 33 | 2021 | 215776 | 0.23 | Why? |
| Risk Factors | 20 | 2021 | 71621 | 0.22 | Why? |
| Limb Salvage | 2 | 2018 | 124 | 0.22 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.21 | Why? |
| Genetic Loci | 2 | 2018 | 439 | 0.21 | Why? |
| Middle Aged | 35 | 2021 | 270681 | 0.20 | Why? |
| Polycystic Kidney Diseases | 1 | 2018 | 6 | 0.20 | Why? |
| Male | 41 | 2021 | 367725 | 0.20 | Why? |
| Thioredoxin Reductase 2 | 1 | 2018 | 1 | 0.20 | Why? |
| Female | 41 | 2021 | 380317 | 0.19 | Why? |
| Transcobalamins | 1 | 2018 | 2 | 0.19 | Why? |
| Length of Stay | 5 | 2020 | 11042 | 0.19 | Why? |
| Retrospective Studies | 19 | 2021 | 105322 | 0.19 | Why? |
| Urinary Tract Physiological Phenomena | 1 | 2018 | 2 | 0.19 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.19 | Why? |
| Vitamin B Deficiency | 1 | 2018 | 8 | 0.19 | Why? |
| Graft Rejection | 3 | 2018 | 1766 | 0.19 | Why? |
| Logistic Models | 4 | 2017 | 9089 | 0.19 | Why? |
| Databases, Factual | 4 | 2017 | 6248 | 0.19 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.19 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.19 | Why? |
| Mucus | 1 | 2020 | 183 | 0.18 | Why? |
| Hypertension, Renal | 1 | 2017 | 9 | 0.18 | Why? |
| Fibrillar Collagens | 1 | 2017 | 6 | 0.18 | Why? |
| Chromosome Mapping | 1 | 2018 | 178 | 0.18 | Why? |
| Collagen Diseases | 1 | 2017 | 10 | 0.18 | Why? |
| Vesicular Transport Proteins | 1 | 2018 | 110 | 0.18 | Why? |
| Glaucoma, Open-Angle | 1 | 2018 | 55 | 0.18 | Why? |
| Parathyroidectomy | 1 | 2017 | 32 | 0.17 | Why? |
| Hyperparathyroidism, Secondary | 1 | 2017 | 47 | 0.17 | Why? |
| Humans | 58 | 2021 | 930598 | 0.17 | Why? |
| Histocompatibility | 1 | 2017 | 53 | 0.17 | Why? |
| Chemokine CXCL9 | 1 | 2018 | 154 | 0.17 | Why? |
| Delayed Graft Function | 1 | 2017 | 52 | 0.17 | Why? |
| Proteinuria | 2 | 2020 | 474 | 0.17 | Why? |
| Islets of Langerhans | 1 | 2018 | 138 | 0.17 | Why? |
| Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
| Canagliflozin | 1 | 2017 | 56 | 0.17 | Why? |
| Population Growth | 1 | 2016 | 37 | 0.17 | Why? |
| Glycation End Products, Advanced | 1 | 2017 | 72 | 0.17 | Why? |
| Genome-Wide Association Study | 3 | 2018 | 1648 | 0.16 | Why? |
| Vitamin B 12 | 1 | 2018 | 132 | 0.16 | Why? |
| Histocompatibility Testing | 1 | 2017 | 219 | 0.16 | Why? |
| United States | 12 | 2020 | 46150 | 0.16 | Why? |
| Postoperative Hemorrhage | 1 | 2018 | 183 | 0.16 | Why? |
| Tryptophan | 1 | 2018 | 218 | 0.16 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.16 | Why? |
| Hypocalcemia | 1 | 2017 | 120 | 0.15 | Why? |
| Loss of Function Mutation | 1 | 2018 | 244 | 0.15 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.15 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.15 | Why? |
| Time Factors | 9 | 2018 | 31397 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.15 | Why? |
| Blood Safety | 1 | 2020 | 459 | 0.15 | Why? |
| Hematoma | 1 | 2018 | 305 | 0.14 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.14 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.14 | Why? |
| Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.14 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.14 | Why? |
| Hospital Costs | 1 | 2017 | 274 | 0.14 | Why? |
| Benzhydryl Compounds | 1 | 2017 | 240 | 0.14 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.14 | Why? |
| End Stage Liver Disease | 1 | 2018 | 418 | 0.13 | Why? |
| Blood Transfusion | 2 | 2020 | 1399 | 0.13 | Why? |
| Wearable Electronic Devices | 1 | 2021 | 694 | 0.13 | Why? |
| Disease Progression | 5 | 2018 | 13580 | 0.13 | Why? |
| Liver Failure | 1 | 2016 | 266 | 0.13 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.13 | Why? |
| Heart Failure | 3 | 2020 | 6638 | 0.13 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.13 | Why? |
| Glucosides | 1 | 2017 | 359 | 0.13 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Treatment Outcome | 9 | 2020 | 51732 | 0.12 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.12 | Why? |
| Young Adult | 12 | 2021 | 93724 | 0.12 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2018 | 6166 | 0.12 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.12 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.12 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.12 | Why? |
| Nephrology | 1 | 2018 | 546 | 0.11 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.11 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.11 | Why? |
| HLA Antigens | 1 | 2017 | 830 | 0.11 | Why? |
| Peritoneal Dialysis | 1 | 2017 | 498 | 0.11 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.11 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.11 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.11 | Why? |
| Adult | 19 | 2021 | 244371 | 0.11 | Why? |
| Case-Control Studies | 5 | 2021 | 17671 | 0.11 | Why? |
| Sexual and Gender Minorities | 1 | 2020 | 1019 | 0.10 | Why? |
| Lymphocytes | 2 | 2020 | 3056 | 0.10 | Why? |
| Ischemia | 1 | 2018 | 901 | 0.10 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.10 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.10 | Why? |
| Prognosis | 8 | 2021 | 32490 | 0.10 | Why? |
| Risk Assessment | 5 | 2021 | 25439 | 0.10 | Why? |
| Heart-Assist Devices | 1 | 2018 | 812 | 0.10 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.10 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Feces | 2 | 2018 | 4235 | 0.09 | Why? |
| Incidence | 6 | 2020 | 25622 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.09 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.08 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.08 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.08 | Why? |
| Tissue and Organ Procurement | 1 | 2017 | 1277 | 0.08 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.08 | Why? |
| Hospitals | 3 | 2020 | 11793 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.07 | Why? |
| Palliative Care | 1 | 2019 | 2665 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.07 | Why? |
| Biomarkers | 5 | 2018 | 23361 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.07 | Why? |
| Registries | 3 | 2018 | 12327 | 0.06 | Why? |
| Electronic Health Records | 3 | 2020 | 3492 | 0.06 | Why? |
| Predictive Value of Tests | 4 | 2020 | 9537 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| CD57 Antigens | 1 | 2021 | 96 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2019 | 3893 | 0.06 | Why? |
| CD56 Antigen | 1 | 2021 | 193 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Prospective Studies | 4 | 2020 | 43301 | 0.05 | Why? |
| Sepsis | 1 | 2016 | 3517 | 0.05 | Why? |
| Hospitals, Private | 1 | 2020 | 198 | 0.05 | Why? |
| Hematuria | 1 | 2020 | 284 | 0.05 | Why? |
| Needles | 1 | 2018 | 87 | 0.04 | Why? |
| Linkage Disequilibrium | 1 | 2018 | 191 | 0.04 | Why? |
| HIV Infections | 2 | 2020 | 11620 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Blood Urea Nitrogen | 1 | 2018 | 206 | 0.04 | Why? |
| Urine | 1 | 2020 | 469 | 0.04 | Why? |
| Medical Writing | 1 | 2018 | 72 | 0.04 | Why? |
| Stress, Physiological | 1 | 2021 | 378 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 325 | 0.04 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Transgender Persons | 1 | 2020 | 322 | 0.04 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.04 | Why? |
| Asian Americans | 1 | 2019 | 387 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2016 | 7301 | 0.04 | Why? |
| Biodiversity | 1 | 2018 | 546 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Hospitals, Urban | 1 | 2020 | 950 | 0.04 | Why? |
| Circadian Rhythm | 1 | 2021 | 607 | 0.04 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.03 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.03 | Why? |
| HIV | 1 | 2020 | 1116 | 0.03 | Why? |
| Colectomy | 1 | 2017 | 327 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| North America | 1 | 2018 | 1400 | 0.03 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.03 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Homosexuality, Male | 1 | 2020 | 1158 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Protective Factors | 1 | 2017 | 1720 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Income | 1 | 2019 | 1564 | 0.02 | Why? |
| Musculoskeletal Diseases | 1 | 2017 | 646 | 0.02 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2018 | 1783 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Plasma | 1 | 2018 | 1809 | 0.02 | Why? |
| Telemedicine | 1 | 2018 | 25032 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Racism | 1 | 2018 | 1462 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.02 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |